MYC and neoplasm: It is tempting to speculate that the transfer of oncogenic kinases via EVs operated by MYC mutant cells could contribute to the aggressive behaviour of the overall tumour mass by promoting the metabolic activity of cancer or stromal cells that do not carry oncogenic mutations.